Osteogenic sarcoma of the extremity with detectable lung metastases at presentation

In the past 20 years, it has been demonstrated that the combination of surgery and chemotherapy improves the prognosis for patients with osteosarcoma of the extremity without detectable metastases at presentation. By contrast, the efficacy of chemotherapy coupled with aggressive surgery has not yet been well established for patients with metastatic disease at diagnosis. The current study evaluates the efficacy of chemotherapy associated with simultaneous surgery of primary and metastatic lesions in patients presenting with osteosarcoma of the extremity with lung metastases.

[1]  U. Pastorino,et al.  Median sternotomy and multiple lung resections for metastatic sarcomas. , 1990, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[2]  M. Usui,et al.  [Adjuvant chemotherapy of osteosarcoma]. , 1990, Gan to kagaku ryoho. Cancer & chemotherapy.

[3]  D. Saltzman,et al.  A new approach to the resection of pulmonary osteosarcoma metastases: results of aggressive metastasectomy. , 1991, La Chirurgia degli organi di movimento.

[4]  N. Jaffe,et al.  Adjuvant methotrexate and citrovorum-factor treatment of osteogenic sarcoma. , 1974, The New England journal of medicine.

[5]  D. Dexter,et al.  Human tumor cell heterogeneity and metastasis. , 1983, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  K. Winkler,et al.  Pulmonary metastases from osteogenic sarcoma: Complete resection and effective chemotherapy contributing to improved prognosis , 1985 .

[7]  E. Holmes,et al.  Pulmonary metastases of stage IIB extremity osteosarcoma and subsequent pulmonary metastases. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  A. Huvos,et al.  Osteogenic sarcoma with clinically detectable metastasis at initial presentation. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  S. Ferrari,et al.  Primary chemotherapy and delayed surgery for nonmetastatic osteosarcoma of the extremities. Results in 164 patients preoperatively treated with high doses of methotrexate followed by cisplatin and doxorubicin , 1993, Cancer.

[10]  J. V. van Horn,et al.  Adriamycin-methotrexate high dose versus adriamycin-methotrexate moderate dose as adjuvant chemotherapy for osteosarcoma of the extremities: a randomized study. , 1986, European journal of cancer & clinical oncology.

[11]  G Rosen,et al.  Chemotherapy for nonmetastatic osteogenic sarcoma: the Memorial Sloan-Kettering experience. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  W. Meyer,et al.  Improved prognosis of children with osteosarcoma metastatic to the lung(s) at the time of diagnosis , 1992, Cancer.

[13]  G. Rosen,et al.  Primary osteogenic sarcoma: the rationale for preoperative chemotherapy and delayed surgery. , 1979, Cancer.

[14]  J. Roth,et al.  Survival following aggressive resection of pulmonary metastases from osteogenic sarcoma: analysis of prognostic factors. , 1983, The Annals of thoracic surgery.

[15]  J. Shuster,et al.  The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity. , 1986, The New England journal of medicine.

[16]  R. Gelber,et al.  Prognostic significance of complete surgical resection of pulmonary metastases in patients with osteogenic sarcoma: analysis of 32 patients. , 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  N. Jaffe,et al.  Histologic evaluation of necrosis in osteosarcoma induced by chemotherapy regional mapping of viable and nonviable tumor , 1985, Cancer.

[18]  H. Jürgens,et al.  Neoadjuvant chemotherapy of osteosarcoma: results of a randomized cooperative trial (COSS-82) with salvage chemotherapy based on histological tumor response. , 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  D. Valteau‐Couanet,et al.  Osteosarcoma recurrences in pediatric patients previously treated with intensive chemotherapy. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  A. Stenwig,et al.  Treatment of osteosarcoma of the extremities with the T-10 protocol, with emphasis on the effects of preoperative chemotherapy with single-agent high-dose methotrexate: a Scandinavian Sarcoma Group study. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  G. Rosen,et al.  Chemotherapy and thoractomy for metastatic osteogenic sarcoma. A model for adjuvant chemotherapy and the rationale for the timing of thoracic surgery , 1978, Cancer.

[22]  N. Martini,et al.  Results of multiple pulmonary resections for metastatic osteogenic sarcoma after two decades , 1991, Journal of surgical oncology.

[23]  M. Simon,et al.  Disparate histologic responses in simultaneously resected primary and metastatic osteosarcoma following intravenous neoadjuvant chemotherapy. , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  J. Høie,et al.  Systemic relapse of patients with osteogenic sarcoma. Prognostic factors for long term survival , 1995, Cancer.